PARIS - February 8, 2019 - After several years of research and development, the start-up Enovap, incubated at the Technopole de l'Aube en Champagne, is launching on the market the first intelligent personal vaporizer for nicotine management. Available at a price of € 129 including tax on the brand's website and in 200 stores in France, this device gives the user control, thus offering a real innovative experience to free yourself from tobacco and nicotine.
AN INNOVATION THAT RESPONDS TO A DOUBLE CHALLENGE!
According to a study by researchers at Queen Mary University in London published on January 30, 2019 in the New England Journal of Medicine1 the electronic cigarette is twice as effective as conventional nicotine substitutes (patch, tablet to suck, chewing gum, etc.) in the context of quitting smoking. Indeed, one year after the start of withdrawal, 18% of patients who quit smoking with the help of electronic cigarettes are still abstinent, against only 9,9% of people who quit with the help of a nicotine replacement. classic. However, this study notes that 80% of people who have weaned themselves from tobacco still use their electronic cigarette and are by definition still dependent on nicotine. Thanks to its double reservoir and its artificial intelligence, Enovap fully meets this double challenge: that of smoking cessation and nicotine.
To read the full press release from Enovap meet here. To find out more, go to the official website of the brand.
